Arcam: AP&C Installs 4th and 5th Atomization Reactors

MÖLNDAL, Sweden--()--Regulatory News:

Arcam AB (STO:ARCM)

Arcam AB, listed on NASDAQ Stockholm, and leading supplier of Additive Manufacturing solutions, announces that its metal powder subsidiary, AP&C, based in Montreal, Canada, is building its fourth and fifth reactors, adding significant capacity to its titanium and nickel super-alloy powder manufacturing operation.A

P&C, the high quality powder manufacturing subsidiary of Arcam, uses proprietary technology for Plasma Atomization. AP&C is continuously developing its technology and the latest advance, increased atomization rates and yield, allows higher manufacturing rates of powder distributions dedicated for Additive Manufacturing equipment.

“The need for high end titanium powder is driven by the fast growth and adoption of Additive Manufacturing. Arcam is determined to serve the industry through cost efficient solutions thus converting traditional manufacturing into Additive Manufacturing. A requisite is to offer the highest quality powder for production at competitive cost”, says Magnus René, CEO of Arcam.

“With this new generation of atomizing technology, AP&C is now in a position to supply aerospace and medical part manufacturers’ titanium powders in volumes needed today and in the future. With a multiple reactor operation, AP&C can produce its standard products on dedicated reactors and equipment, therefore eliminating cross-contamination risks”, says Jacques Mallette, President of AP&C, www.advancedpowders.com.

Arcam Group provides cost-efficient Additive Manufacturing solutions for production of metal components. Arcam’s Electron Beam Melting (EBM®) technology offers design freedom combined with excellent material properties and high productivity. Arcam is, through its solution orientation and comprehensive product offering, an innovative partner for advanced manufacturing, primarily for the aerospace and medical industries. Arcam offers EBM systems through Arcam AB in Sweden, powder metals through AP&C in Canada and implant contract manufacturing through DiSanto in the U.S.The company is listed on Nasdaq Stockholm and the Head Office is located in Mölndal, Sweden.

________________________________________________________________________________________

Arcam AB • Krokslätts Fabriker 27A • SE-431 37 Mölndal, Sweden • 46-31-710 32 00 • www.arcam.com

This information was brought to you by Cision http://news.cision.com

Contacts

Arcam AB
Magnus René, CEO
Tel: 46 31 710 32 00
alt. cell: 46 702 79 89 99
e-mail: magnus.rene@arcam.com

Contacts

Arcam AB
Magnus René, CEO
Tel: 46 31 710 32 00
alt. cell: 46 702 79 89 99
e-mail: magnus.rene@arcam.com